ПОВОЛЖСКИЙ
ОНКОЛОГИЧЕСКИЙ
ВЕСТНИК
radiotherapy plus concurrent chemotherapy with
chemotherapy alone in gastric cancer patients with
D2 resection // Radiother. Oncol. – 2012. – Vol. 104. –
P. 361-366.
17. Cunningham D., Allum W.H., Stenning S.P. et al.
Perioperative chemotherapy versus surgery alone for
resectable gastroesophageal cancer // N. Engl. J. Med. –
2006. – Vol. 355. – P. 11-20.
18. Dikken J.L., van Sandick J.W., Maurits Swellengrebel
H.A. et al. Neo-adjuvant chemotherapy followed
by surgery and chemotherapy or by surgery and
chemoradiotherapy for patients with resectable
gastric cancer (CRITICS) // BMC Cancer. – 2011. –
Vol. 11. – P. 329.
19. Cunningham D., Chua Y.J. East meets West in the
treatment of gastric cancer // N. Engl. J. Med. – 2007. –
Vol. 357. – P. 1863-1865.
72
3(25)’2016
20. Bang Y.J., Van Cutsem E., Feyereislova A. et al.
Trastuzumab in combination with chemotherapy
versus chemotherapy alone for treatment of HER2positive advanced gastric or gastro-oesophageal
junction cancer (ToGA): A phase 3, open-label,
randomised controlled trial // Lancet. – 2010. –
Vol. 376. – P. 687-697.
21. Kataoka K., Tokunaga M., Mizusawa J. et al. Stomach
Cancer Study Group/Japan Clinical Oncology Group.
A randomized Phase II trial of systemic chemotherapy
with and without trastuzumab followed by surgery in
HER2-positive advanced gastric or esophagogastric
junction adenocarcinoma with extensive lymph node
metastasis: Japan Clinical Oncology Group study
JCOG1301 (Trigger Study) // Jpn J. Clin. Oncol. – 2015. –
Vol. 45. – Р. 1082-1086. doi: 10.1093/jjco/hyv134.
Клинические исследования и опыт в онкологии